# Application of Magnesium-rich Artificial Cerebrospinal Fluid in Subarachnoid Hemorrhage

> **NCT04819451** · NA · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 72 (estimated)

## Conditions studied

- Intracranial Hemorrhage

## Interventions

- **OTHER:** Magnesium-Rich Artificial Cerebrospinal Fluid (MACSF)

## Key facts

- **NCT ID:** NCT04819451
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-30
- **Primary completion:** 2024-01-01
- **Final completion:** 2024-02-01
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2022-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04819451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04819451, "Application of Magnesium-rich Artificial Cerebrospinal Fluid in Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04819451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*